WallStSmart
SXTC

China SXT Pharmaceuticals Inc

NASDAQ: SXTC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$1.65
-9.25% today

Updated 2026-06-04

Market cap
$10.08M
P/E ratio
P/S ratio
6.55x
EPS (TTM)
$-57.15
Dividend yield
52W range
$1 – $312
Volume
0.1M

China SXT Pharmaceuticals Inc (SXTC) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+75.0%
Most recent quarter

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+23.5%
Last 1 reports
Positive reaction rate
100%
1 of 1 quarters
Largest single-day move
+23.5%
2025-12-31
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2025-12-31$-0.05$1.41$1.74+23.5%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-09-30$0.00$-0.05
2025-06-30$0.00$-1.02$455709.00
2024-12-31$0.00$-1.99$455709.00
2022-06-30$0.00$-2.03$-11.50M
2021-12-31$0.00$-0.20$787304.00
2021-06-30$0.00$-0.27
2020-12-31$0.00$0.10
2020-09-30$0.00$-0.13
2020-06-30$0.00$-0.42
2020-03-31$0.00$-0.10
2019-12-31$0.00$-0.59
2019-09-30$0.00$-0.59
2019-06-30$0.00$0.07
2019-03-31$0.00$-0.21

Frequently asked questions

Has China SXT Pharmaceuticals Inc beaten earnings estimates?

China SXT Pharmaceuticals Inc has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports. A consistent beat record suggests management guides conservatively and the business has predictable momentum, which tends to support the stock through earnings season.

How does SXTC stock react to earnings?

SXTC has moved an average of +23.5% the day after earnings over its last 1 reports, finishing higher after 1 of them. Next-day moves show how the market digests results in the short term, and repeated dips on strong reports usually mean expectations were already priced in.